AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 208 filers reported holding AMICUS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $335,000 | -2.9% | 26,853 | +5.9% | 0.36% | +1.7% |
Q1 2019 | $345,000 | +66.7% | 25,357 | +17.5% | 0.36% | +47.3% |
Q4 2018 | $207,000 | -18.2% | 21,585 | +2.4% | 0.24% | +20.9% |
Q3 2018 | $253,000 | -24.7% | 21,088 | -2.0% | 0.20% | -24.4% |
Q2 2018 | $336,000 | – | 21,522 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 22,792,634 | $284,452,000 | 8.05% |
Perceptive Advisors | 21,509,486 | $268,438,000 | 6.16% |
SECTORAL ASSET MANAGEMENT INC | 3,324,623 | $41,491,000 | 4.96% |
Palo Alto Investors LP | 7,796,299 | $97,298,000 | 4.73% |
Avoro Capital Advisors LLC | 10,000,000 | $124,800,000 | 4.31% |
SPHERA FUNDS MANAGEMENT LTD. | 2,510,320 | $31,329,000 | 4.29% |
Novo Holdings A/S | 2,317,870 | $28,927,000 | 4.05% |
Ghost Tree Capital, LLC | 1,450,000 | $18,096,000 | 3.75% |
Copernicus Capital Management, LLC | 325,000 | $4,056,000 | 3.61% |
Boxer Capital, LLC | 2,325,000 | $29,016,000 | 2.50% |